Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum LED Medical Diagnostics Inc LEDIF

"LED Medical Diagnostics Inc is a Canada based company engaged in development and marketing of a medical device under the trade name VELscope which is used in the dental industry to help identify oral soft tissue abnormalities including those which may be cancerous or precancerous. In addition, the company also features a Digital division that provides dentists and oral health diagnostic... see more

GREY:LEDIF - Post Discussion

LED Medical Diagnostics Inc > 2019 outlook?
View:
Post by deepthinker63 on Apr 30, 2019 9:06am

2019 outlook?

Q4 wasn’t great.  Not much info on 2019.  I’m guessing they’re going to need more money.  How much is the question.   2019 revenues maybe $16 million, of which 50% is “recurring”.  I assume the margins on recurring revenue are higher.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities